Research workbench
AlphaFold monomer V2.0 prediction for ornithine carbamoyltransferase (A1VEP9)
Analyse AlphaFold monomer V2.0 prediction for ornithine carbamoyltransferase (A1VEP9) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- Accession
- A1VEP9
- Type
- protein
- Length
- 300 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0xbff27Dc0a932A6E0d9Fe883AAbD1BF27bB95A69F
- Molecule
- Ornithine carbamoyltransferase
- UniProt
- A1VEP9
- Pockets
- 2 · best druggability 0.57
Structure
1 distinct chain · 46% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Ornithine carbamoyltransferase | protein | 300 | 46% helix, 16% strand | A1VEP9 |
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 142 | 0.57 | 0.83 | 34 | empty |
| 2 | 51 | 0.36 | 0.80 | 16 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A1VEP9
- Elsewhere: UniProt A1VEP9 · AlphaFold DB A1VEP9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.